albuferon

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2006
01220002006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Human Genome Sciences Inc (HGS), in collaboration with Novartis AG, is developing Albuferon-alpha, a long-acting injectable human… (More)
Is this relevant?
2003
2003
The long half-life and stability of human serum albumin (HSA) make it an attractive candidate for fusion to short-lived… (More)
Is this relevant?
2002
2002
Interferon-alpha (IFN-alpha) is indicated for the treatment of certain viral infections including hepatitis B and C, and cancers… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2002
2002
Interferon(IFN) is indicated for the treatment of certain viral infections including hepatitis B and C, and cancers such as… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2000
2000
MD) hopes to re-patent many of the biotechnology industry’s most celebrated therapeutic proteins and return them to market under… (More)
Is this relevant?
2000
2000
MD) hopes to re-patent many of the biotechnology industry’s most celebrated therapeutic proteins and return them to market under… (More)
Is this relevant?